Lonafarnib, Zoledronic Acid, and Pravastatin ( DrugBank: Pravastatin, Zoledronic acid, Lonafarnib )

1 disease

ID	Disease name (Link within this page)	Number of trials
333	Hutchinson-Gilford syndrome	1

333. Hutchinson-Gilford syndrome

Clinical trials : 8 / Drugs : 8 - (DrugBank : 3) / Drug target genes : 4 - Drug target pathways : 6

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00916747 (ClinicalTrials.gov)	August 2009	5/6/2009	Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria	An Open Label Phase II Trial of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Hutch ...	Progeria	Drug: Lonafarnib, Zoledronic Acid, and Pravastatin	Boston Children's Hospital	Schering-Plough;Merck Sharp & Dohme LLC;Eiger BioPharmaceuticals	Active, not recruiting	N/A	N/A	All	85	Phase 2	United States

First Previous1Next Last